I. Pham

1.5k total citations
37 papers, 1.2k citations indexed

About

I. Pham is a scholar working on Cardiology and Cardiovascular Medicine, Genetics and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, I. Pham has authored 37 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 9 papers in Genetics and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in I. Pham's work include Cardiovascular Function and Risk Factors (8 papers), Cardiac Imaging and Diagnostics (7 papers) and High Altitude and Hypoxia (6 papers). I. Pham is often cited by papers focused on Cardiovascular Function and Risk Factors (8 papers), Cardiac Imaging and Diagnostics (7 papers) and High Altitude and Hypoxia (6 papers). I. Pham collaborates with scholars based in France, United States and Germany. I. Pham's co-authors include Jean‐Paul Richalet, A Nitenberg, Emmanuel Cosson, Serge Adnot, M C Fournié-Zaluski, Paul Valensi, P Gratadour, M Déchaux, Julien V. Brugniaux and J B Michel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Diabetes Care and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

I. Pham

36 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. Pham France 20 450 325 258 191 187 37 1.2k
G. Riegger Germany 21 579 1.3× 191 0.6× 156 0.6× 250 1.3× 71 0.4× 56 1.4k
Jean St‐Louis Canada 26 363 0.8× 236 0.7× 66 0.3× 347 1.8× 49 0.3× 99 2.4k
A. Fournier France 21 240 0.5× 297 0.9× 78 0.3× 343 1.8× 52 0.3× 79 1.6k
F Fyhrquist Finland 21 492 1.1× 219 0.7× 74 0.3× 326 1.7× 52 0.3× 72 1.4k
M Fujishima Japan 20 220 0.5× 120 0.4× 97 0.4× 312 1.6× 53 0.3× 65 1.2k
Luigi Mattiello Italy 26 664 1.5× 115 0.4× 83 0.3× 321 1.7× 68 0.4× 67 1.7k
Zaiming Luo United States 18 410 0.9× 134 0.4× 97 0.4× 341 1.8× 57 0.3× 27 1.2k
Marie‐Luise Gross Germany 20 397 0.9× 191 0.6× 65 0.3× 276 1.4× 66 0.4× 30 1.5k
Jill Donaldson United Kingdom 19 167 0.4× 236 0.7× 103 0.4× 507 2.7× 88 0.5× 42 1.8k
Andrea Baessler Germany 20 345 0.8× 50 0.2× 146 0.6× 330 1.7× 111 0.6× 53 1.1k

Countries citing papers authored by I. Pham

Since Specialization
Citations

This map shows the geographic impact of I. Pham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Pham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Pham more than expected).

Fields of papers citing papers by I. Pham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Pham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Pham. The network helps show where I. Pham may publish in the future.

Co-authorship network of co-authors of I. Pham

This figure shows the co-authorship network connecting the top 25 collaborators of I. Pham. A scholar is included among the top collaborators of I. Pham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Pham. I. Pham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Nguyen, M.T., I. Pham, Paul Valensi, et al.. (2014). Flow-mediated-paradoxical vasoconstriction is independently associated with asymptomatic myocardial ischemia and coronary artery disease in type 2 diabetic patients. Cardiovascular Diabetology. 13(1). 20–20. 19 indexed citations
3.
Nguyen, M.T., I. Pham, D. S. Chemla, Paul Valensi, & Emmanuel Cosson. (2013). Decreased stroke volume–brachial pulse pressure ratio in patients with type 2 diabetes over 50 years: The role of peripheral neuropathy. Nutrition Metabolism and Cardiovascular Diseases. 23(11). 1093–1100. 4 indexed citations
4.
Pham, I., Grégoire Wuerzner, Jean‐Paul Richalet, Séverine Peyrard, & Michel Azizi. (2012). Bosentan Effects in Hypoxic Pulmonary Vasoconstriction: Preliminary Study in Subjects with or without High Altitude Pulmonary Edema‐History. Pulmonary Circulation. 2(1). 28–33. 16 indexed citations
5.
Prendki, Virginie, Jérôme Stirnemann, I. Pham, et al.. (2011). Amebic Liver Abscess, Extensive Thrombosis, and Patent Cardiac Foramen Ovale. Journal of Travel Medicine. 18(6). 427–429. 4 indexed citations
6.
Pham, I., Grégoire Wuerzner, Jean‐Paul Richalet, S. Peyrard, & Michel Azizi. (2010). Endothelin receptors blockade blunts hypoxia‐induced increase in PAP in humans. European Journal of Clinical Investigation. 40(3). 195–202. 24 indexed citations
7.
Cosson, Emmanuel, M.T. Nguyen, I. Pham, et al.. (2009). N‐terminal pro‐B‐type natriuretic peptide: an independent marker for coronary artery disease in asymptomatic diabetic patients. Diabetic Medicine. 26(9). 872–879. 23 indexed citations
8.
Rostoker, Guy, Pierre Andrivet, I. Pham, Mireille Griuncelli, & Serge Adnot. (2009). Accuracy and limitations of equations for predicting the glomerular filtration rate during follow-up of patients with non-diabetic nephropathies. BMC Nephrology. 10(1). 16–16. 15 indexed citations
9.
Richalet, Jean‐Paul, Maria C. Rivera, Maxime Maignan, et al.. (2008). Acetazolamide for Monge's Disease. American Journal of Respiratory and Critical Care Medicine. 177(12). 1370–1376. 59 indexed citations
10.
Rostoker, Guy, Pierre Andrivet, I. Pham, Mireille Griuncelli, & Serge Adnot. (2007). A modified Cockcroft-Gault formula taking into account the body surface area gives a more accurate estimation of the glomerular filtration rate. Journal of Nephrology. 20(5). 576–585. 63 indexed citations
12.
Richalet, Jean‐Paul, P Gratadour, Paul Robach, et al.. (2004). Sildenafil Inhibits Altitude-induced Hypoxemia and Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 171(3). 275–281. 170 indexed citations
13.
Adam, Micheline, Sylvia Sanquer, Emmanuel Teíger, et al.. (2001). Adenovirus-mediated transfer of the atrial natriuretic peptide gene in rat pulmonary vascular smooth muscle cells leads to apoptosis. Journal of Laboratory and Clinical Medicine. 137(3). 155–164. 3 indexed citations
14.
Pham, I., Pierre Andrivet, Saı̈d Sediame, et al.. (2001). Increased erythropoietin synthesis in patients with COLD or left heart failure is related to alterations in renal haemodynamics. European Journal of Clinical Investigation. 31(2). 103–109. 26 indexed citations
15.
Chetboul, Valérie, Micheline Adam, Andreja Ambriović‐Ristov, et al.. (1999). Expression of Biologically Active Atrial Natriuretic Factor Following Intrahepatic Injection of a Replication-Defective Adenoviral Vector in Dogs. Human Gene Therapy. 10(2). 281–290. 7 indexed citations
16.
Pham, I., Saı̈d Sediame, P Chabrier, et al.. (1998). Effects of ANF Infusion on the Renal Responses to Lower-Body Negative Pressure in Humans. Journal of Cardiovascular Pharmacology. 31(5). 669–676. 3 indexed citations
17.
Pham, I., et al.. (1996). Effects of angiotensin-converting enzyme and neutral endopeptidase inhibitors: influence of bradykinin. European Journal of Pharmacology. 296(3). 267–276. 13 indexed citations
18.
Pham, I., et al.. (1995). Acute hemodynamic effects of combined inhibition of neutral endopeptidase and angiotensin converting enzyme in spontaneously hypertensive rats. Fundamental and Clinical Pharmacology. 9(2). 153–160. 5 indexed citations
19.
Pham, I., Abdelaziz Amrani, M C Fournié-Zaluski, et al.. (1993). Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.. Journal of Pharmacology and Experimental Therapeutics. 265(3). 1339–1347. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026